Regulatory aspects of vascular dementia in the United States

International Psychogeriatrics

Volumn 15, Issue SUPPL. 1, 2003, Pages 293-295

  Oliva, Armando ^a   Mani, Ranjit ^a   Katz, Russell ^a  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

Drug development; Food and Drug Administration, FDA; Treatment; U.S. regulatory; Vascular dementia

Indexed keywords

AGED; ALZHEIMER DISEASE; CEREBROVASCULAR DISEASE; COGNITIVE DEFECT; CONFERENCE PAPER; DEMENTIA; DRUG RESEARCH; FOOD AND DRUG ADMINISTRATION; HUMAN; MULTIINFARCT DEMENTIA; UNITED STATES;

AGED; DEMENTIA, VASCULAR; ETHICS, CLINICAL; GOVERNMENT REGULATION; GUIDELINES; HUMANS; RESEARCH; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 0141596206     PISSN: 10416102     EISSN: None     Source Type: Journal    
DOI: 10.1017/S1041610203009360     Document Type: Conference Paper

References (1)

1. Roman, G. C., Tatemichi, T. K., Erkinjuntti, T., Cummings, J. L., Masdeu, J. C., et al. (1993). Vascular dementia: Diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology, 43, 250-260.